Listed

Celldex Therapeutics, Inc.: Form 10-Q for the period ended Sep 30, 2016

Filed with the SEC on Nov 7, 2016 and accepted by EDGAR at Nov 7, 2016, 16:16 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-07-01 to 2016-09-30$2.2mus-gaap:Revenues
Revenue9 months2016-01-01 to 2016-09-30$4.9mus-gaap:Revenues
Research and development3 months2016-07-01 to 2016-09-30$25.0mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2016-01-01 to 2016-09-30$78.2mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2016-07-01 to 2016-09-30−$30.0mus-gaap:OperatingIncomeLoss
Operating income9 months2016-01-01 to 2016-09-30−$98.1mus-gaap:OperatingIncomeLoss
Net income3 months2016-07-01 to 2016-09-30−$29.6mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income9 months2016-01-01 to 2016-09-30−$96.2mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2016-07-01 to 2016-09-30−$0.29us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2016-01-01 to 2016-09-30−$0.97us-gaap:EarningsPerShareBasicAndDiluted
Capital expenditure9 months2016-01-01 to 2016-09-30$2.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-09-30$31.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-09-30$209.7mus-gaap:AssetsCurrent
Total assetsAt period end2016-09-30$251.9mus-gaap:Assets
Current liabilitiesAt period end2016-09-30$18.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-09-30$34.9mus-gaap:Liabilities
Shareholders' equityAt period end2016-09-30$217.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-16-155185. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.